Kelyniam Global (OTC:KLYG), a maker of custom cranial implants, today announced that Terrance Kurtenbach, CFO, will present live at the Life Sciences ...

Objectives The development of simple tools to identify individuals at high risk of coronary heart disease (CHD) would enable rapid implementation of preventive measures. This study was designed to ...